Security Snapshot

Sanara MedTech Inc. - Common Stock, $0.001 par value (SMTI) Institutional Ownership

CUSIP: 79957L100

13F Institutional Holders and Ownership History from Q4 2020 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

73

Shares (Excl. Options)

1.78MFull value: 1,784,731 · shares · 30 Jun 2026

Price

$23.59

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, $0.001 par value
Symbol
SMTI on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
1,784,731
Latest holder snapshot 5 signals
Total 13F value
$42,109,264
Portfolio coverage rank
0%
Share change
+306,650
Value change
+$7,378,582
Number of holders
73
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
8,944,624
SEC-reported price per share
$35.00
Insider filing price
$35.00
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • SMTI - Sanara MedTech Inc. - Common Stock, $0.001 par value is tracked under CUSIP 79957L100.
  • 73 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 65 to 73 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $25.65MFull value: $25,649,814 · USD · 31 Mar 2026
    to
    $42.11MFull value: $42,109,264 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 73 institutions filings for Q2 2026.

Open SEC evidence

Security key

79957L100

13F reference period

Q2 2026

13F holders

73

13D/G owners

1

CIK / CUSIP context first

Open Q2 2026 holders SMTI full holder history Sanara MedTech Inc. SEC filings Sanara MedTech Inc. company facts Sanara MedTech Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
SMTI
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAIRD TRUST Co 0% -94% $362,290 -$12,707,527 21,075 -97% BAIRD TRUST Co 31 Mar 2026
As of 30 Jun 2026, 73 institutional investors reported holding
1.78MFull value: 1,784,731 · shares · 30 Jun 2026
shares of Sanara MedTech Inc. - Common Stock, $0.001 par value (SMTI). This represents 20% of the company’s total
8.94MFull value: 8,944,624 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
18%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 2.8% 248,827 +8.8% 0% $5,869,829
VANGUARD CAPITAL MANAGEMENT LLC 2.2% 194,897 +29% 0% $4,597,620
ROYAL BANK OF CANADA 1.5% 130,994 -0.29% 0% $3,091,000
Stonebridge Wealth Management, LLC 1.4% 129,452 -5.4% 2.7% $3,053,773
AQR CAPITAL MANAGEMENT LLC 1.3% 112,207 +181% 0% $2,646,952
GEODE CAPITAL MANAGEMENT, LLC 1% 89,179 +4.1% 0% $2,104,778
GOLDMAN SACHS GROUP INC 0.83% 74,198 +244% 0% $1,750,331
RENAISSANCE TECHNOLOGIES LLC 0.75% 67,400 +4.2% 0% $1,589,966
STATE STREET CORP 0.71% 63,469 +1.2% 0% $1,497,234
Squarepoint Ops LLC 0.6% 53,811 -27% 0% $1,269,401
JANE STREET GROUP, LLC 0.57% 50,806 +32% 0% $1,198,514
MARSHALL WACE, LLP 0.55% 49,457 -35% 0% $1,166,690
CITADEL ADVISORS LLC 0.41% 36,813 +18% 0% $868,419
NORTHERN TRUST CORP 0.41% 36,441 +9.6% 0% $859,644
JACOBS LEVY EQUITY MANAGEMENT, INC 0.35% 31,644 0% $746,482
Walleye Capital LLC 0.34% 30,465 0% $718,669
LOS ANGELES CAPITAL MANAGEMENT LLC 0.3% 26,830 0% $632,920
VANGUARD FIDUCIARY TRUST CO 0.29% 26,027 +2.6% 0% $613,977
Evernest Financial Advisors, LLC 0.29% 25,700 0.13% $606,263
MORGAN STANLEY 0.26% 23,628 +20% 0% $557,384
VANGUARD PORTFOLIO MANAGEMENT LLC 0.26% 23,417 +29% 0% $552,407
HSBC HOLDINGS PLC 0.26% 23,254 +35% 0% $549,725
Baird Financial Group, Inc. 0.24% 21,075 0% 0% $497,159
Qube Research & Technologies Ltd 0.23% 20,400 -23% 0% $481,236
PRICE T ROWE ASSOCIATES INC /MD/ 0.22% 19,252 +77% 0% $455,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
24
Headline period
Q2 2026
Rows shown
1-24 of 24
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 330,445 $11,611,813 +$7,975,019 $35.14 13
2026 Q2 1,784,731 $42,109,264 +$7,378,582 $23.59 73
2026 Q1 1,492,653 $25,649,814 -$8,388,094 $17.18 65
2025 Q4 1,935,148 $45,190,323 +$18,180,986 $23.35 53
2025 Q3 1,137,683 $36,088,261 +$1,057,717 $31.73 57
2025 Q2 1,106,235 $31,408,453 +$1,940,235 $28.39 51
2025 Q1 916,291 $28,277,079 -$1,441,540 $30.87 47
2024 Q4 952,781 $31,629,770 +$4,711,802 $33.20 49
2024 Q3 810,359 $24,503,030 +$2,164,185 $30.24 42
2024 Q2 730,401 $20,613,392 +$1,060,836 $28.22 38
2024 Q1 679,473 $25,138,649 -$220,177 $37.00 41
2023 Q4 685,113 $28,157,833 +$2,262,867 $41.10 46
2023 Q3 630,117 $19,626,710 -$1,563,167 $31.13 42
2023 Q2 666,943 $26,745,074 +$8,027,572 $40.10 47
2023 Q1 462,617 $19,085,507 +$4,275,450 $41.25 35
2022 Q4 381,841 $17,371,120 +$2,570,809 $45.50 31
2022 Q3 334,830 $9,938,000 +$2,183,700 $29.70 26
2022 Q2 261,136 $5,447,000 -$453,195 $20.87 19
2022 Q1 275,288 $7,787,000 -$1,912,163 $28.45 19
2021 Q4 341,977 $10,175,000 -$1,642,750 $29.66 21
2021 Q3 382,356 $13,067,000 +$4,029,831 $34.23 22
2021 Q2 268,928 $9,723,000 -$8,724,209 $36.94 18
2021 Q1 557,420 $17,214,000 +$13,229,620 $31.15 19
2020 Q4 104,642 $5,198,000 +$5,198,000 $49.89 14
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .